Jump to content

Recommended Posts

Angel’s Fang enhancement looks awesome for a duelist.

 

it will probably get hit by an errata, but it doesn’t specify melee or ranged weapon, so a gravis captain getting Sus2 on bolter isn’t bad. Not great into monsters or vehicles, but helps you just spam shots, to fish for 5s and 6s in the wound roll.

 

but Sus2 on a PF with 3 attacks and Sus2 on a the extra attacks is fantastic.

 

sanguinary guard with spears are looking good. With a strat getting them up to S7 18/33 AP-3 2D rerolling wounds will be very mean.

jump captain gets the Strat for free, so combo angel’s fang with this and a PF, and you’ve got a very scary unit.

Edited by Inquisitor_Lensoven

I think it looks fun, still helps with wounding having army wide reroll 1s. - not based on charging either.

 

still gives a bonus attack on the charge  and actually incentivises going battle shocked too with another attack on top - I like it.

 

stratagems look reasonable too, again similar but slightly different theme to the LAS.

 

feel like it would be fun to mess with, does give a vibe of flesh tearers to me.

16 minutes ago, Blindhamster said:

I think it looks fun, still helps with wounding having army wide reroll 1s. - not based on charging either.

 

still gives a bonus attack on the charge  and actually incentivises going battle shocked too with another attack on top - I like it.

 

stratagems look reasonable too, again similar but slightly different theme to the LAS.

 

feel like it would be fun to mess with, does give a vibe of flesh tearers to me.

It’s LAG and the DC detachment smashed together basically 

Create an account or sign in to comment

You need to be a member in order to leave a comment

Create an account

Sign up for a new account in our community. It's easy!

Register a new account

Sign in

Already have an account? Sign in here.

Sign In Now
  • Recently Browsing   0 members

    • No registered users viewing this page.
×
×
  • Create New...

Important Information

By using this site, you agree to our Terms of Use.